Month: August 2017
-
App Users Report Lower Blood Glucose Levels
A study of individuals with diabetes using a mobile app to record blood glucose levels, reported more than a 1 percent average reduction in blood glucose readings after a median of 4 months.
-
Forensic Genomics Company Spun-Off From Illumina
A new company is being established to provide genomics analysis systems for law enforcement, spun-off from a leading maker of genomics systems.
-
Experimenting With Your Earnings
If you want to make a go of things, it’s best to follow a set process. And, you need to follow it in every different aspect to tackle business in the right way.
-
Clinical Trial Okayed for Parkinson’s Drug Implant
A maker of implants for long-term release of drugs to treat chronic diseases says the Food and Drug Administration approved a clinical trial to test its implant for Parkinson’s disease.
-
Engineered Insulin-Producing Cells to Be Grown in Lab
A team from three universities is developing in the lab synthetic islet cells, the cells that produce insulin in the pancreas, for eventual transplantation in people with type 1 diabetes.
-
Developing Your Online Platform? Here’s How
It is now more important than ever to have your own online platform for advertisements and marketing purposes.
-
Algorithms, Imaging Help Predict Alzheimer’s Onset
Neurologists and computer scientists developed techniques for analyzing images to determine the chance of someone progressing from mild cognitive impairment to Alzheimer’s disease.
-
Smartphones Capturing Multiple Sclerosis Data
A large-scale research study of physical challenges and symptoms in people with multiple sclerosis in the U.S. is capturing its data with smartphones rather than by visiting clinics.
-
Five Novel Ideas for a Home-Based Business
The best of these ideas are based on providing services that people need. If it is not a hands-on sort of business, even better.
-
Vaccines in Development for Opioid Combinations
Researchers studying the immune system as a weapon against opioid addiction say they can develop vaccines that block combinations of opioids, like those sold on the street.